SAFE ORTHOPAEDICS announced the commercial launch in Europe of a bone substitute for its Walnut cage for cervical surgeries. This device, developed in conjunction with a specialist in synthetic bone substitutes, aims to promote bone growth and thus to make vertebral fusion safer. In parallel, the SteriSpineCC range (Walnut cage and associated single-use ancillary) has also received (510k) marketing approval from the US Food and Drug Administration (FDA). Although it is not commercialized in the United States, this technology will gain more rapid approval in certain countries such as in Latin America and the Asia-Pacific region.